Bioventus Inc (BVS) News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bioventus Reports Third Quarter Financial Results

Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* GrowthQ3 Gross Margin Expanded...

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”...

Form S-3 - Registration statement under Securities Act of 1933

Form 8-K - Current report

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the...

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Bioventus Reports Second Quarter Financial Results

Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9%Q2 Gross Margin Expanded 350 bps and Adjusted Gross...